• The UK approves Botox® (onabotulinumtoxinA), for axillary hyperhidrosis.
  • Canada approves Botox, for axillary hyperhidrosis, focal muscle spasticity, and cosmetic treatment of wrinkles at the browline.
  • President Bush declines to ratify the Biological and Toxins Weapons Convention Treaty, arguing that the inspections protocol would jeopardize commercial biotechnology industries in the US.